ACNS1821- A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
Adam Green
Study ID
Protocol Number: 23-0048
More information available at ClinicalTrials.gov: NCT05099003
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers